Xometry, Inc. (XMTR) Stock Price & Analysis
Xometry, Inc. (XMTR) closed at USD 99.54 on Thursday, October 15, 2026, up 4.61% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 95.15; the Oct 15, 2026 session ranged USD 92.01–100.22 on volume of 801,236 shares. Market capitalization is $5.71B, with a 52-week range of USD 35.86–112.94 (NMS). Source: Nexqual, retrieved October 16, 2026 at 05:19 UTC.
Also available as compact Markdown for AI agents: nexqual.com/XMTR.md
Key facts (XMTR)
- Last four reported quarters (through Jun 30, 2026): revenue $808M, net income -$30.8M (-3.8% margin) (SEC filings).
- 1 of 80 tracked superinvestors hold XMTR (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 28 Form 4 filings, $13.9M; 4 not under a Rule 10b5-1 plan ($6.7M).
- Analysts: Buy (mean 2.00 on a 1–5 scale) (12 analysts), mean target USD 112.09 (range 95–126).
- Total return with dividends: 1Y +111.5% vs S&P 500 +18.1%; 5Y +66.2% vs S&P 500 +85.1%.
- Next earnings: 2026-11-03, EPS estimate USD 0.19, revenue estimate $236M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (XMTR)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $218M | $381M | $463M | $546M | $687M | $808M |
| Gross profit | $57.1M | $146M | $178M | $216M | $269M | — |
| Operating income | -$58.7M | -$77.1M | -$73.6M | -$56.1M | -$45.5M | -$30.6M |
| Net income | -$61.4M | -$79.1M | -$67.5M | -$50.4M | -$61.7M | -$30.8M |
| EPS (diluted) | -$2.33 | -$1.68 | -$1.41 | -$1.03 | — | — |
| Free cash flow | -$74.8M | -$76.2M | -$48.4M | -$33.5M | -$24.1M | — |
| Gross margin | 26.2% | 38.3% | 38.5% | 39.5% | 39.1% | — |
| Operating margin | -26.9% | -20.2% | -15.9% | -10.3% | -6.6% | -3.8% |
| Net margin | -28.1% | -20.8% | -14.6% | -9.2% | -9.0% | -3.8% |
| Revenue growth | +54.4% | +74.5% | +21.7% | +17.7% | +25.9% | — |
| Cash + short-term investments | $117M | $319M | $269M | $240M | $219M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (XMTR)
P/S 7.1x · P/B 9.6x · Earnings yield -0.54%
Superinvestors (SEC 13F-HR, Q2 2026) (XMTR)
1 of 80 tracked investors hold XMTR. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Henry Ellenbogen | Durable Capital Partners | 0.95% | $98.0M | Added +1731.9% |
Insider sales (SEC Form 4, open-market, last ~7 months) (XMTR)
24 of 28 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan |
|---|---|---|---|---|---|---|
| 2026-10-12 | Sahni Sanjeev Singh | Chief Executive Officer | 1,500 | $163K | 0.8% | Yes |
| 2026-10-01…2026-10-02 | Altschuler Randolph | Director | 15,721 | $1.6M | 0.7% | Yes |
| 2026-10-02 | Sahni Sanjeev Singh | Chief Executive Officer | 1,112 | $115K | 0.6% | Yes |
| 2026-10-02 | Raghavan Vaidyanathan | Chief Technology Officer | 1,866 | $193K | 1.4% | Yes |
| 2026-09-14 | Sahni Sanjeev Singh | Chief Executive Officer | 1,500 | $128K | 0.8% | Yes |
| 2026-09-01 | Altschuler Randolph | Director | 10,000 | $908K | 0.4% | Yes |
| 2026-08-28…2026-08-31 | Weymouth Katharine | Director | 10,000 | $948K | 22.1% | No |
| 2026-08-27 | Raghavan Vaidyanathan | Chief Technology Officer | 5,000 | $484K | 3.6% | No |
| 2026-08-19 | Rollins Emily | Director | 5,000 | $422K | 24.8% | Yes |
| 2026-08-17 | Sahni Sanjeev Singh | Chief Executive Officer | 1,500 | $135K | 0.8% | Yes |
| 2026-08-10…2026-08-11 | Rosati Fabio | Director | 10,000 | $911K | 9.8% | No |
| 2026-08-06 | Miln James | Chief Financial Officer | 1,500 | $132K | 0.8% | Yes |
| 2026-07-02 | Altschuler Randolph | Director | 5,722 | $534K | 0.2% | Yes |
| 2026-07-02 | Raghavan Vaidyanathan | Chief Technology Officer | 1,866 | $174K | 1.3% | Yes |
| 2026-07-02 | Dutt Subir | Chief Sales Officer | 1,073 | $100K | 1.1% | Yes |
| 2026-07-01…2026-07-02 | Miln James | Chief Financial Officer | 3,892 | $369K | 2.1% | Yes |
| 2026-06-01 | Miln James | Chief Financial Officer | 1,500 | $145K | 0.8% | Yes |
| 2026-05-27 | Dutt Subir | Chief Sales Officer | 2,500 | $238K | 2.6% | Yes |
| 2026-05-21 | Altschuler Randolph | Chief Executive Officer | 50,000 | $4.4M | 2% | No |
| 2026-05-18 | Dutt Subir | Chief Sales Officer | 4,943 | $441K | 4.8% | Yes |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Analysts (XMTR)
Consensus Buy (mean 2.00 on a 1–5 scale), 12 analysts; mean target USD 112.09 (low 95, high 126).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-22 | Rosenblatt | Target raised | Buy | $110 → $120 |
| 2026-09-21 | Citizens | Reiterated | Market Outperform | $120 |
| 2026-08-20 | Rosenblatt | Initiated | Buy | $110 |
| 2026-08-05 | UBS | Target raised | Neutral | $88 → $95 |
| 2026-08-05 | Citigroup | Target raised | Buy | $98 → $110 |
| 2026-08-05 | RBC Capital | Target raised | Sector Perform | $85 → $100 |
| 2026-08-05 | Goldman Sachs | Target raised | Neutral | $78 → $104 |
| 2026-08-05 | Cantor Fitzgerald | Target raised | Overweight | $85 → $110 |
Total return (dividends reinvested) (XMTR)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | +111.5% | +66.2% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +112.1% | +10.7% |
| Volatility (annualized) | 81.8% | 81.5% |
| Max drawdown | -49.9% (Feb 2026→Mar 2026) | -81.1% (Sep 2022→Jul 2024) |
Key Statistics (as of October 16, 2026 at 05:19 UTC)
| Price | USD 99.54 |
|---|---|
| Change | ▲ 4.61% (up) |
| Previous Close | USD 95.15 |
| Open | USD 92.01 |
| Day Range | USD 92.01 – 100.22 |
| 52-Week Range | USD 35.86 – 112.94 |
| Volume | 801,236 shares |
| Market Cap | $5.71B |
| Exchange | NMS |
Technical Analysis (XMTR)
Nexqual's technical model rates XMTR "NEUTRAL" based on 3 bullish and 2 bearish signals across 127 daily candles, as of October 16, 2026 at 05:19 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.2 (neutral) |
| vs SMA50 | Above (USD 95.43) |
| MACD | 2.46 (positive) |
Analyst Ratings (XMTR)
Wall Street analysts rate XMTR "Buy" based on 12 analysts, with a mean price target of USD 112.09 (range USD 95–126), per Nexqual as of October 16, 2026 at 05:19 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 12 |
| Mean Target | USD 112.09 |
| High Target | USD 126 |
| Low Target | USD 95 |
| Buy / Hold / Sell | 9 / 3 / 0 |
Earnings (XMTR)
| Next Earnings Date | 2026-11-03 |
|---|---|
| EPS Estimate | USD 0.19 |
| Revenue Estimate | $235.58M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.16 vs est 0.16 ▼ miss |
| 2026-03-31 | USD 0.12 vs est 0.09 ▲ beat |
| 2025-12-31 | USD 0.16 vs est 0.12 ▲ beat |
| 2025-09-30 | USD 0.11 vs est 0.1 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Financials & Fundamentals (XMTR)
| Total Revenue | $807.53M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +41.10% |
| Gross Margin | +38.75% |
| Operating Margin | -2.44% |
| Profit Margin | -3.82% |
| ROE | -7.10% |
| Debt / Equity | 0.57 |
| Current Ratio | 3.21 |
| Total Cash | $516.67M |
| Total Debt | $339.77M |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | -$24.09M (-3.5% of revenue) |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Financial Health Score (XMTR)
Nexqual rates Xometry, Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:19 UTC.
| Growth | Strong — Revenue +26% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 39%, operating -2% |
| Balance Sheet | Strong — $517M cash vs $340M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$24M (FY ended Dec 2025, 10-K), burning cash |
| Efficiency | Critical — ROE -7%, ROA -2.2% |
Ownership (XMTR)
| Insider Ownership | +6.90% |
|---|---|
| Institutional Ownership | +100.70% |
| Shares Outstanding | 55.85M |
| Float | 52.12M |
| Short % of Float | +9.63% |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Leadership (XMTR)
Xometry, Inc. is led by Sanjeev Singh Sahni (age 49), President, CEO & Director, per Nexqual as of October 16, 2026 at 05:19 UTC.
| President, CEO & Director | Sanjeev Singh Sahni (age 49) |
|---|---|
| CFO & Principal Accounting Officer | James Miln C.M.A. (age 51) |
| Chief Technology Officer | Vaidyanathan Raghavan (age 43) |
| Vice President of Investor Relations | Shawn Christopher Milne |
| Chief Marketing Officer | Stephany Verstraete (age 56) |
Major Backers & Investors (XMTR)
Notable institutional backers of Xometry, Inc. include Primecap Management Company, PRIMECAP Odyssey Funds-PRIMECAP Odyssey Growth Fund, FMR, LLC, according to Nexqual as of October 16, 2026 at 05:19 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Primecap Management Company | 12.98% |
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Growth Fund | 9.61% |
| FMR, LLC | 7.66% |
| Eventide Asset Management LLC | 4.21% |
| MUTUAL FUND SERIES TRUST-Eventide Gilead Fund | 4.1% |
| Hood River Capital Management LLC | 3.89% |
| Driehaus Capital Management, LLC | 3.46% |
| First Trust Advisors LP | 3.41% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 12.88% |
| BlackRock | 9.83% |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| POOL | Pool Corporation | USD 169.12 | ▲ 5.31% |
| CNM | Core & Main, Inc. | USD 41.79 | ▲ 2.38% |
| SITE | SiteOne Landscape Supply, Inc. | USD 94.27 | ▲ 4.34% |
| QXO | QXO, Inc. | USD 11.18 | ▲ 1.45% |
| DXPE | DXP Enterprises, Inc. | USD 177.73 | ▼ 3.01% |
| DNOW | DNOW Inc. | USD 15.02 | ▼ 2.28% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:19 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt